:max_bytes(150000):strip_icc()/GettyImages-1332376463-1c4b24a82cd149e1a4916d6a9b99d05b.jpg?w=780&resize=780,470&ssl=1 "AbbVie Stock Advances After Beat-and-Raise Earnings Report")
Key Takeaways The S&P 500 edged 0.1% higher on Monday, April 28, eking out a fifth straight winning session to…
Read More »AbbVie
:max_bytes(150000):strip_icc()/GettyImages-2211092898-a8a080c72a9046adb2cde196637ef4a6.jpg?w=780&resize=780,470&ssl=1 "AbbVie Stock Rises on Stronger-Than-Expected Results, Profit Outlook Lift")
Key Takeaways AbbVie’s first-quarter sales and adjusted earnings per share topped estimates. The drugmaker lifted its full-year adjusted EPS forecast…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2196063137-d33ea240a79542a48f498e1da92cc39f.jpg?w=780&resize=780,470&ssl=1 "Apple, AbbVie, Deckers Outdoor, and More")
Key Takeaways U.S. equities were mostly higher at midday on positive tech earnings news and a report showing December inflation…
Read More »:max_bytes(150000):strip_icc()/GettyImages-1970099302-41bb08e8e83543a4854b6ba0bab4c244.jpg?w=780&resize=780,470&ssl=1 "AbbVie Stock Soars as Biotech Tops Sales Estimates, Raises Outlook")
Key Takeaways AbbVie’s fourth-quarter revenue exceeded forecasts on higher sales of its Skyrizi and Rinvoq drugs to treat inflammation. The…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2184833968-7c355e309d3c47f5afb4848e49053a41.jpg?w=780&resize=780,470&ssl=1 "AbbVie Takes .5B Impairment Charge for Failed Schizophrenia Drug")
Key Takeaways AbbVie said it would take a $3.5 billion dollar impairment charge related to the failure of a drug…
Read More »